NCT02321241 - Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMD | Biotech Hunter

Enrollment

236

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

January 18, 2017

Study Completion Date

August 18, 2017

Conditions

Wet Macular Degeneration

Interventions

DRUG

Aflibercept (EYLEA, BAY-86-5321)

"1. st year: 3 monthly injections followed by 1 injection every two months~2. nd year and following: injection according the visual and anatomical results observed the 1st year"

Trial Locations (1)

Unknown

Multiple Locations